Role of 18F-FDG PET/CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment with 2025/2026 EANM/SNMMI Guidelines. (2026). Bangladesh Journal of Nuclear Medicine, 29(1), 28-35. https://doi.org/10.3329/bjnm.v29i1.89278